Intech Investment Management LLC Has $1.14 Million Stock Position in AdaptHealth Corp. (NASDAQ:AHCO)

Intech Investment Management LLC grew its position in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 100.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 119,417 shares of the company's stock after purchasing an additional 59,767 shares during the period. Intech Investment Management LLC owned about 0.09% of AdaptHealth worth $1,137,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the company. Corient Private Wealth LLC increased its holdings in AdaptHealth by 37.9% during the 4th quarter. Corient Private Wealth LLC now owns 21,155 shares of the company's stock valued at $201,000 after purchasing an additional 5,811 shares in the last quarter. Royce & Associates LP increased its stake in shares of AdaptHealth by 29.0% in the fourth quarter. Royce & Associates LP now owns 1,002,755 shares of the company's stock valued at $9,546,000 after buying an additional 225,350 shares in the last quarter. Swiss National Bank raised its holdings in shares of AdaptHealth by 1.7% in the fourth quarter. Swiss National Bank now owns 171,900 shares of the company's stock valued at $1,636,000 after buying an additional 2,900 shares during the last quarter. Johnson Investment Counsel Inc. lifted its position in AdaptHealth by 33.3% during the 4th quarter. Johnson Investment Counsel Inc. now owns 20,779 shares of the company's stock worth $198,000 after buying an additional 5,189 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new stake in AdaptHealth during the 4th quarter worth about $197,000. Institutional investors own 82.67% of the company's stock.

AdaptHealth Stock Up 1.8 %

Shares of NASDAQ:AHCO traded up $0.19 during midday trading on Wednesday, hitting $10.48. The stock had a trading volume of 1,198,556 shares, compared to its average volume of 1,162,071. The company has a market cap of $1.41 billion, a P/E ratio of -6.35, a PEG ratio of 1.08 and a beta of 1.30. AdaptHealth Corp. has a 12 month low of $8.35 and a 12 month high of $11.90. The business's 50-day simple moving average is $10.01 and its 200-day simple moving average is $10.17. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. UBS Group dropped their target price on AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a research report on Thursday, February 13th. Canaccord Genuity Group raised their target price on shares of AdaptHealth from $13.00 to $14.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Robert W. Baird boosted their price target on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a research note on Thursday, February 27th. Royal Bank of Canada raised their price objective on shares of AdaptHealth from $11.00 to $14.00 and gave the company an "outperform" rating in a research note on Wednesday, February 26th. Finally, Truist Financial upped their target price on shares of AdaptHealth from $12.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $13.80.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.